Thursday, April 25, 2024
4/25/2024
ABSTRACT QUARTZ VALLEY INDIAN RESERVATION TRIBAL OPIOID RESPONSE TI-18-016 Opioid use disorder (OUD) is a chronic disease and is treatable. Quartz Valley Indian Reservation will create a Strategic Plan in coordination with California Tribal Epidemiology Center and initiate a Tribal Opioid Response Program to include Medication Assisted Treatment in support of recovery from OUD. MAT approaches have been shown to substantially improve outcomes for OUD. QVIR will serve up to sixty patients in the first year. Goal 1. Develop and provide opioid misuse prevention, treatment, and recovery support services for the purposes of addressing the opioid abuse and overdose crisis within the local tribes. Objective 1. ATHC will provide Food Drug Administration-approved medication-assisted treatment (MAT) to be provided to those diagnosed with OUD. Objective 2. Employ effective prevention and recovery support services including inpatient referrals. Objective 3. Improve storage and security for MAT related treatment medications. Goal 2. Within 60 days of award complete a comprehensive strategic plan or review existing Needs Assessment based on the most current epidemiological data for the tribe, to address the gaps in prevention, treatment, and recovery identified by the tribe. Objective 1. Work with California Tribal Epidemiology Center CTEC to assess the impact of the grant. Objective 2. Coordinate with California Indian Health Board (CRIHB) and/or CTEC to develop strategic plan. Goal 3. Implement service delivery models that enable the full spectrum of treatment and recovery support services that facilitate positive treatment outcomes and long-term recovery. Objective 1. Identify and develop effective prevention strategies. Objective 2. Identify and develop strategies to purchase and disseminate identified MAT medications including Naloxone and provide training on its use to first responders and other tribal members. Objective 3. Provide assistance to patients with treatment costs and develop other strategies to eliminate or reduce treatment costs for under- and uninsured patient. Goal 4. Address barriers to receiving MAT by reducing the cost of treatment, developing innovative systems of care to expand access to treatment, engage and retain patients in treatment, address discrimination associated with accessing treatment, including discrimination that limits access to MAT, and support long-term recovery. Objective 1. Incorporate culturally appropriate and traditional practices into our program design and implementation. Objective 2. Support innovative telehealth strategies to increase the capacity of our community to support OUD prevention, treatment, and recovery. Objective 3. In the MAT program co-occurring substance use and mental health disorders are the expectation and not the exception. The MAT team will have therapists who are able to treat both disorders. The MAT provider will either provide psychiatric medication services or coordinate the patient’s psychiatric medication needs via Telehealth.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
